Ozempic
Ozempic is semaglutide approved for type 2 diabetes, though it's frequently prescribed off-label for weight loss. It contains the same active ingredient as Wegovy but at lower doses.
Brand-Name Cost
$900-1,000/month
Compounded Cost
$149-249/month
Type
GLP-1 Agonist
How Ozempic Works
Ozempic mimics the GLP-1 hormone to improve blood sugar control and reduce appetite. It stimulates insulin release when blood sugar is high and slows gastric emptying.
Effectiveness
While approved for diabetes, Ozempic users typically see weight loss of 10-15% of body weight. It's less than Wegovy's higher doses but still significant.
Dosing
Weekly injection starting at 0.25mg for 4 weeks, then 0.5mg. Can increase to 1mg or 2mg based on glycemic response. Lower maximum dose than Wegovy.
FDA-Approved Uses
- Type 2 diabetes management
- Cardiovascular risk reduction in adults with type 2 diabetes and heart disease
Get GLP-1 Updates
Weekly pricing updates, FDA news, and new provider reviews delivered to your inbox.